This article addresses some current issues about genetic polymorphisms studied in the non-small-cell lung cancer translational field. Furthermore, it discusses about new potential biomarkers regarding lung cancer risk and prognosis.
Lung neoplasms; Polymorphism; genetic; Tumor makers; biological; Prognosis